TY - JOUR
T1 - 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO)
AU - Latib, Azeem
AU - Ruparelia, Neil
AU - Menozzi, Alberto
AU - Castriota, Fausto
AU - Micari, Antonio
AU - Cremonesi, Alberto
AU - De Felice, Francesco
AU - Marchese, Alfredo
AU - Tespili, Maurizio
AU - Presbitero, Patrizia
AU - Sgueglia, Gregory A.
AU - Buffoli, Francesca
AU - Tamburino, Corrado
AU - Varbella, Ferdinando
AU - Colombo, Antonio
N1 - Funding Information:
Please note: The BELLO study was supported by an unrestricted grant from Invatec S.p.A , who had no role in the design, conduct, or reporting of the study. The industry had no role in the preparation, review, or approval of this manuscript. Dr. Latib serves on a Medtronic advisory board. Dr. Cremonesi is a consultant for Medtronic and Boston Scientific. Dr. Varbella has received research grants from Medtronic , Boston Scientific , Abbott Vascular , Terumo , Sanitex , Sorin , Empass , MeDi , Kardia , St. Jude Medical , The Medicine Company , and Eli Lilly and Company . All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2015/7/1
Y1 - 2015/7/1
UR - http://www.scopus.com/inward/record.url?scp=84937675835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937675835&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2015.04.008
DO - 10.1016/j.jcin.2015.04.008
M3 - Letter
C2 - 26205451
AN - SCOPUS:84937675835
SN - 1936-8798
VL - 8
SP - 1132
EP - 1134
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 8
ER -